Adenosine Intravenous and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Adenosine Intravenous and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: adenosine
Brand name: Adenocard, Adenoscan, Adeno-jec, My-O-Den, Myoden
Synonyms: Adenosine
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adenosine Intravenous-Tilia Fe
- Adenosine Intravenous-Tiludronate
- Adenosine Intravenous-Timentin
- Adenosine Intravenous-Timentin Add-Vantage
- Adenosine Intravenous-Timentin Injection
- Adenosine Intravenous-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Tildrakizumab-asmn Subcutaneous-Adenovirus Vaccine
- Tildrakizumab-asmn Subcutaneous-Adenovirus vaccine, live
- Tildrakizumab-asmn Subcutaneous-Adhansia XR
- Tildrakizumab-asmn Subcutaneous-Adipex
- Tildrakizumab-asmn Subcutaneous-Adipex-P